Search Results - Arun Swaminath
- Showing 1 - 18 results of 18
-
1
-
2
Video capsule endoscopy in inflammatory bowel disease by Arun Swaminath, Peter Legnani, Asher Kornbluth
Published 2010Revisão -
3
-
4
-
5
The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information by Arun Swaminath, Eric P Berlin, Adam S. Cheifetz, Ed Hoffenberg, Jami Kinnucan, Laura Wingate, Sarah Buchanan, Nada Zmeter, David T. Rubin
Published 2018Revisão -
6
CX3CR1+ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22 by Randy Longman, Gretchen E. Diehl, Daniel Victorio, Jun R. Huh, Carolina Galan, Emily R. Miraldi, Arun Swaminath, Richard Bonneau, Ellen Scherl, Dan R. Littman
Published 2014Artigo -
7
Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease by Matthew Bohm, Ronghui Xu, Yiran Zhang, Sashidhar Varma, Monika Fischer, Gursimran Kochhar, Brigid S. Boland, Siddharth Singh, Robert Hirten, Ryan C. Ungaro, Eugenia Shmidt, Karen Lasch, Vipul Jairaith, David Hudesman, Sam S. Chang, Dana J. Lukin, Arun Swaminath, Bruce E. Sands, Jean‐Frédéric Colombel, Sunanda V. Kane, Edward V. Loftus, Bo Shen, Corey A. Siegel, William J. Sandborn, Parambir S. Dulai
Published 2020Artigo -
8
Doubling the infliximab dose versus halving the infusion intervals in Crohnʼs disease patients with loss of response by Lior H. Katz, Javier P. Gisbert, Beth Manoogian, Kirk Lin, Casper Steenholdt, Gerassimos J. Mantzaris, Ashish Atreja, Yulia Ron, Arun Swaminath, Somal Shah, Ailsa Hart, Péter L. Lakatos, Pierre Ellul, Eran Israeli, Mads Naundrup Svendsen, C. Janneke van der Woude, Κωνσταντίνος Κατσάνος, Laura Yun, Epameinondas V. Tsianos, Torben Nathan, María T. Abreu, Iris Dotan, Bret A. Lashner, Jørn Brynskov, Jonathan P. Terdiman, Peter Higgins, María Chaparro, Shomron Ben–Horin
Published 2012Artigo -
9
Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease by Eugenia Shmidt, Gursimran Kochhar, Justin Hartke, Prianka Chilukuri, Joseph Meserve, Khadija Chaudrey, Jenna L. Koliani‐Pace, Robert Hirten, David M. Faleck, Morris Barocas, Michelle Luo, Karen Lasch, Brigid S. Boland, Siddharth Singh, Niels Vande Casteele, Sashidhar Sagi, Monika Fischer, Sam S. Chang, Matthew Bohm, Dana J. Lukin, Keith Sultan, Arun Swaminath, David Hudesman, Nitin Gupta, Sunanda V. Kane, Edward V. Loftus, William J. Sandborn, Corey A. Siegel, Bruce E. Sands, Jean‐Frédéric Colombel, Bo Shen, Parambir S. Dulai
Published 2018Artigo -
10
A Randomized Trial Comparing the Specific Carbohydrate Diet to a Mediterranean Diet in Adults With Crohn’s Disease by James D. Lewis, Robert S. Sandler, Carol Brotherton, Colleen Brensinger, Hongzhe Li, Michael D. Kappelman, Scott G. Daniel, Kyle Bittinger, Lindsey Albenberg, John F. Valentine, John S. Hanson, David L. Suskind, Andrea H. Meyer, Charlene Compher, Meenakshi Bewtra, Akriti Saxena, Angela Dobes, Benjamin L. Cohen, Ann D. Flynn, Monika Fischer, Sumona Saha, Arun Swaminath, Bruce Yacyshyn, Ellen Scherl, Sara Horst, Jeffrey R. Curtis, Kimberly Braly, Lisa Nessel, Maureen McCauley, Liam McKeever, Hans Herfarth
Published 2021Artigo -
11
Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases by Joseph Meserve, Satimai Aniwan, Jenna L. Koliani‐Pace, Preeti Shashi, Aaron Weiss, David M. Faleck, Adam C. Winters, Shreva Chablaney, Gursimran Kochhar, Brigid S. Boland, Siddharth Singh, Robert Hirten, Eugenia Shmidt, Justin Hartke, Prianka Chilukuri, Matthew Bohm, Sashidhar Sagi, Monika Fischer, Dana J. Lukin, David Hudesman, Sam S. Chang, Youran Gao, Keith Sultan, Arun Swaminath, Nitin Gupta, Sunanda V. Kane, Edward V. Loftus, Bo Shen, Bruce E. Sands, Jean‐Frédéric Colombel, Corey A. Siegel, William J. Sandborn, Parambir S. Dulai
Published 2018Artigo -
12
Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn’s Disease But Not Ulcerative Colitis by David M. Faleck, Adam C. Winters, Shreya Chablaney, Preeti Shashi, Joseph Meserve, Aaron Weiss, Satimai Aniwan, Jenna L. Koliani‐Pace, Gursimran Kochhar, Brigid S. Boland, Siddharth Singh, Robert Hirten, Eugenia Shmidt, Varun Kesar, Karen Lasch, Michelle Luo, Matthew Bohm, Sashidhar Varma, Monika Fischer, David Hudesman, Sam S. Chang, Dana J. Lukin, Keith Sultan, Arun Swaminath, Nitin Gupta, Corey A. Siegel, Bo Shen, William J. Sandborn, Sunanda V. Kane, Edward V. Loftus, Bruce E. Sands, Jean‐Frédéric Colombel, Parambir S. Dulai, Ryan C. Ungaro
Published 2019Artigo -
13
Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn’s Disease by Parambir S. Dulai, Brigid S. Boland, Siddharth Singh, Khadija Chaudrey, Jenna L. Koliani‐Pace, Gursimran Kochhar, Malav P. Parikh, Eugenia Shmidt, Justin Hartke, Prianka Chilukuri, Joseph Meserve, Diana Whitehead, Robert Hirten, Adam C. Winters, Leah Katta, Farhad Peerani, Neeraj Narula, Keith Sultan, Arun Swaminath, Matthew Bohm, Dana J. Lukin, David Hudesman, John T. Chang, Jesús Rivera–Nieves, Vipul Jairath, Guangyong Zou, Brian G. Feagan, Bo Shen, Corey A. Siegel, Edward V. Loftus, Sunanda V. Kane, Bruce E. Sands, Jean‐Frédéric Colombel, William J. Sandborn, Karen Lasch, Charlie Cao
Published 2018Artigo -
14
Open: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium by Neeraj Narula, Farhad Peerani, Joseph Meserve, Gursimran Kochhar, Khadija Chaudrey, Justin Hartke, Prianka Chilukuri, Jenna L. Koliani‐Pace, Adam C. Winters, Leah Katta, Eugenia Shmidt, Robert Hirten, David M. Faleck, Malav P. Parikh, Diana Whitehead, Brigid S. Boland, Siddharth Singh, Sashidhar Sagi, Monika Fischer, Sam S. Chang, Morris Barocas, Michelle Luo, Karen Lasch, Matthew Bohm, Dana J. Lukin, Keith Sultan, Arun Swaminath, David Hudesman, Nitin Gupta, Bo Shen, Sunanda V. Kane, Edward V. Loftus, Corey A. Siegel, Bruce E. Sands, Jean‐Frédéric Colombel, William J. Sandborn, Parambir S. Dulai
Published 2018Artigo -
15
Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis by Dana J. Lukin, David M. Faleck, Ronghui Xu, Yiran Zhang, Aaron Weiss, Satimai Aniwan, Siri Kadire, Gloria Tran, Mahmoud Rahal, Adam C. Winters, Shreya Chablaney, Jenna L. Koliani‐Pace, Joseph Meserve, James P. Campbell, Gursimran Kochhar, Matthew Bohm, Sashidhar Varma, Monika Fischer, Brigid S. Boland, Siddharth Singh, Robert Hirten, Ryan C. Ungaro, Karen Lasch, Eugenia Shmidt, Vipul Jairath, David Hudesman, Sam S. Chang, Arun Swaminath, Bo Shen, Sunanda V. Kane, Edward V. Loftus, Bruce E. Sands, Jean‐Frédéric Colombel, Corey A. Siegel, William J. Sandborn, Parambir S. Dulai
Published 2020Artigo -
16
Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis by Parambir S. Dulai, Siddharth Singh, Niels Vande Casteele, Joseph Meserve, Adam C. Winters, Shreya Chablaney, Satimai Aniwan, Preeti Shashi, Gursimran Kochhar, Aaron Weiss, Jenna L. Koliani‐Pace, Youran Gao, Brigid S. Boland, John T. Chang, David M. Faleck, Robert Hirten, Ryan C. Ungaro, Dana J. Lukin, Keith Sultan, David Hudesman, Sam S. Chang, Matthew Bohm, Sashidhar Varma, Monika Fischer, Eugenia Shmidt, Arun Swaminath, Nitin Gupta, Maria Rosario, Vipul Jairath, Leonardo Guizzetti, Brian G. Feagan, Corey A. Siegel, Bo Shen, Sunanda V. Kane, Edward V. Loftus, William J. Sandborn, Bruce E. Sands, Jean‐Frédéric Colombel, Karen Lasch, Charlie Cao
Published 2020Artigo -
17
Surgery for Crohn’s Disease Is Associated With a Dysbiotic Microbiome and Metabolome: Results From Two Prospective Cohorts by James D. Lewis, Scott G. Daniel, Hongzhe Li, Fuhua Hao, Andrew D. Patterson, Aaron L. Hecht, Colleen Brensinger, Gary D. Wu, Kyle Bittinger, Douglas C. Wolf, Bridget M. Hron, John S. Hanson, Sanjib Mohanty, Ronald Fogel, L. Campbell Levy, Heba Iskandar, Monika Fischer, Benjamin L. Cohen, Arun Swaminath, Sunanda V. Kane, Robert P. McCabe, Eugene F. Yen, Stephen B. Hanauer, David Hudesman, Anita Afzali, Colleen Kelly, John R. Weber, Uma Mahadevan, Hans Herfarth, J.N. Katz, Sasha Taleban, David T. Rubin, Bruce Yachyshyn, Gorman Reynolds, Mark E. Gerich, Gerald W. Dryden, Sandra Quezada, Peter Higgins, Eugenia Shmidt, James D. Lewis, Marc Schwartz, Ann D. Flynn, Sumona Saha, Sara Horst, Michael Chiorean, Patrick D. Green, Ellen Scherl, Robert S. Sandler, Carol Brotherton, Lindsey Albenberg, John F. Valentine, David L. Suskind, Andrea H. Meyer, Charlene Compher, Meenakshi Bewtra, John S. Hanson, Manreet Kaur, Themistocles Dassopoulos, Scott B. Snapper, Joshua R. Korzenik, Matthew Bohm, Laura E. Raffals, Poonam Beniwal‐Patel, David Hudesman, Kirk Russ, Loren Brook, Joel Pekow, Raymond K. Cross, Uni Wong, Shrinivas Bishu, Meenakshi Bewtra, James D. Lewis, Richard H. Duerr, Sumona Saha, Freddy Caldera, Elizabeth Scoville, Parakkal Deepak, Matthew A. Ciorba
Published 2024Artigo -
18
A clinical decision support tool may help to optimise vedolizumab therapy in Crohn’s disease by Parambir S. Dulai, Aurélien Amiot, Laurent Peyrin–Biroulet, Vipul Jairaith, Mélanie Serrero, Jérôme Filippi, Siddharth Singh, Benjamin Pariente, Edward V. Loftus, Xavier Roblin, Sunanda V. Kane, Anthony Buisson, Corey A. Siegel, Yoram Bouhnik, William J. Sandborn, Karen Lasch, Maria Rosario, Brian G. Feagan, Daniela Bojic, Caroline Trang-Poisson, Bo Shen, Romain Altwegg, Bruce E. Sands, Jean‐Frédéric Colombel, Franck Carbonnel, Gursimran Kochhar, Joseph Meserve, Maria Barsky, Brigid S. Boland, Charlotte Gagnière, Marc-André Bigard, Camille Zallot, Jean–Charles Grimaud, Xavier Hébuterne, Maria Nachury, Pierre Desreumaux, Émilie Del Tedesco, Gilles Bommelaer, Jenna L. Koliani‐Pace, Carmen Stéfanescu, Arnaud Boureille, Robert Hirten, Ryan C. Ungaro, Thibaud Vaysse, Matthew Bohm, Sashidhar Varma, Monika Fischer, David Hudesman, Shannon Chang, Anne Bourrier, Philippe Seksik, Laurent Beaugerie, Jacques Cosnes, Harry Sokol, Cécilia Landman, Dana J. Lukin, Aaron Weiss, Philippe Marteau, Xavier Dray, Stéphane Nancey, Gilles Boschetti, David Laharie, Florian Poullenot, Matthieu Allez, Jean-Marc Gornet, C Baudry, Guillaume Savoye, Jacques Moreau, Lucine Vuitton, Stéphane Koch, S Viennot, Alexandre Aubourg, Laurence Picon, Anne-Laure Pelletier, Gaëlle Sickersen, Guillaume Bouguen, Vered Abitbol, Stanislas Chaussade, Stéphane Nahon, Mathurin Fuméry, Betsy Winkfield, Hedia Brixi‐Benmansour, Rodica Gincul, Jean-Christophe Barberis, Bruno Bonaz, Christophe Michiels, Frank Zerbib, Marie Bourrier de Beauregard, Christophe Locher, Sophie Davin-Couve, Armelle Poirette, L Guillem, Monica Stetiu-Mocanu, Beau Philippe, Sylvain Béorchia, Jawad Al Qaddi, Arun Swaminath, Getaid Observ-Ibd, Victory Cohorts Collaboration
Published 2019Artigo
Search Tools:
Related Subjects
Medicine
Disease
Internal medicine
Gastroenterology
Crohn's disease
Inflammatory bowel disease
Ulcerative colitis
Vedolizumab
Adverse effect
Infliximab
Surgery
Biology
Confidence interval
Odds ratio
Retrospective cohort study
Calprotectin
Cohort
Concomitant
Discontinuation
Environmental health
Hazard ratio
Inflammation
Intensive care medicine
Logistic regression
Population
Receiver operating characteristic
Adalimumab
Antagonist
Balloon
Balloon dilation